4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Aytu BioPharma, Inc. (AYTU) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Denver, United States with about 82 employees. Its market capitalization is roughly $24 million. In the fiscal year ended 2025-06-30, AYTU reported $66M in revenue and ($14M) in net income.
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.
Interactive charts & full statements → Open the AYTU valuation workbench →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | $66M | $65M | $107M | $97M |
| Gross Profit | $46M | $49M | $67M | $52M |
| Operating Income (EBIT) | $2M | $1M | ($12M) | ($36M) |
| Net Income | ($14M) | ($16M) | ($17M) | ($109M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $12M | $15M | $14M | $15M | $18M | — |
| Gross Profit | $8M | $10M | $9M | $10M | $13M | — |
| Operating Income (EBIT) | ($4M) | ($2M) | ($2M) | $1M | $2M | — |
| Net Income | ($6M) | ($11M) | $2M | ($20M) | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | $124M | $118M | $136M | $138M |
| Total Liabilities | $105M | $90M | $97M | $93M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AYTU viewer.
About TickerBase · Data methodology & sources